Home › Funds › RA CAPITAL MANAGEMENT, L.P. › MIRM

RA CAPITAL MANAGEMENT, L.P. position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

RA CAPITAL MANAGEMENT, L.P. reported holding 318,554 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$37.3M, representing 0.32% of its reported portfolio and ranking #47 among its reported holdings. RA CAPITAL MANAGEMENT, L.P. has disclosed MIRM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)318.55K sh
Reported value held$37.29M
Portfolio Weight0.32%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How RA CAPITAL MANAGEMENT, L.P.'s MIRM position evolved

RA CAPITAL MANAGEMENT, L.P. first disclosed a stake in MIRM in Q1 2026 at 318,554 shares (US$29.4M). The position peaked in Q2 2026 at 318,554 shares, worth US$37.3M. Across 2 filings, RA CAPITAL MANAGEMENT, L.P. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 318,554 shares valued at US$37.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 318.55K $29.43M New
Q2 2026 318.55K $37.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has RA CAPITAL MANAGEMENT, L.P. held MIRM?

RA CAPITAL MANAGEMENT, L.P. has disclosed MIRM holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in MIRM?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 318.55K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $37.29M, representing 0.32% of its reported portfolio and ranking #47.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling MIRM?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. held unchanged its position in MIRM. The position peaked in Q2 2026 at 318.55K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.